In a recent interview, Phillip Koo, MD, discussed emerging trends with AI, theranostics and empowered patients, and how these developments may lead to challenges and potential opportunities for radiologists and nuclear medicine physicians.
|Slideshows|July 26, 2023
Research Highlights from the SNMMI 2023 Conference
Author(s)Diagnostic Imaging Staff
Catch up on emerging research findings presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) 2023 conference.
Advertisement
From molecular imaging insights on obesity and kinetic modeling to bolster PET tracer quantification for cardiac amyloidosis to the role of PET imaging in de-escalating breast cancer treatment, promising research for challeging conditions was in abundance at the Society of Nuclear Imaging and Molecular Imaging (SNMMI) 2023 conference in Chicago. Review the slideshow below to check out some of the new research highlights from the conference.
Advertisement
Related to this article
How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.
In the third of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss recent developments with autonomous AI in breast imaging and share their perspective on the overall potential of AI to help mitigate the radiologist shortage.
In a recent interview, Amir Iravani, MD, FRACP, discussed the radiotherapeutic agent 177Lu-edotreotide and new dosimetry data from the COMPETE trial that was recently presented at the ASTRO conference.
In the second of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss how to handle disagreements with adjunctive AI in breast imaging, whether to include AI assessments in PACS, and whether patients should pay for the use of adjunctive AI.
Newly published preclinical research signals a substantial conceptual shift with a potential role of photon-counting CT in targeting specific biological processes.
The future of AI in radiology lies in its potential capability to forge connections and enhance efficiencies for enterprise-wide workflows.
In a new podcast episode, Joseph Cavallo, MD, MBA, offered his perspective on AI integration, potential efficiency gains, navigating post-deployment monitoring and how to incorporate AI literacy into radiology resident training.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears MRI-Based AI Software for Prognostic Evaluation of Patients with Mild Cognitive Impairment
2
How AI, Theranostics and More Empowered Patients Have Led to Significant Changes in Radiology
3
What’s Next for AI in Radiology?: Facilitating Data Orchestration Over Fragmentation
4
FDA Clears AI-Enabled FFR-IQ Software for Estimating Fractional Flow Reserve from CCTA
5